mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.7 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |